Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $7.16 Million |
|---|---|
| Enterprise Value | $1.15 Million |
| Earnings per Share | $-0.9 |
| Beta | 0.99 |
| Outstanding Shares | 24,711,391 |
| P/E Ratio | -0.5 |
|---|---|
| PEG | 1.44 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 32776.54 |
| Enterprise Value to EBIT | -0.1 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering fr...